MYC and sarcomatoid carcinoma: Silencing TNFR1 in SCC cells inhibits cell proliferation, reduces UBCH10, Twist1, Sox2, and c-Myc levels, converts spindle cell carcinomas into well-differentiated SCCs, dampened tumor burden, and blocked metastasis.